Corrigendum: Serum CYR61 is associated with airway inflammation and is a potential biomarker for severity in chronic obstructive pulmonary disease

Affiliations

Zhu-Xia Tan: Department of Toxicology, Anhui Medical University, Hefei, China
Zhu-Xia Tan: Second Affiliated Hospital, Anhui Medical University, Hefei, China
Lin Fu: Second Affiliated Hospital, Anhui Medical University, Hefei, China
Wen-Jing Wang: Second Affiliated Hospital, Anhui Medical University, Hefei, China
Ping Zhan: Second Affiliated Hospital, Anhui Medical University, Hefei, China
Hui Zhao: Second Affiliated Hospital, Anhui Medical University, Hefei, China
Hua Wang: Department of Toxicology, Anhui Medical University, Hefei, China
De-Xiang Xu: Department of Toxicology, Anhui Medical University, Hefei, China

Abstract

No abstracts available.